ROCURONIUM Side Effects

5207042-7 | Bradycardia, Cardiac Arrest, Cardiac Failure, Hypertension
on Jan 02, 2007 Male patient from UNITED STATES , child 3 years of age, weighting 29.54 lb, was diagnosed with intubation and was treated with Rocuronium (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cardiac arrest (What is cardiac arrest?), cardiac failure, hypertension. Rocuronium dosage: 15 Mg Once Intravenous (nos). During the same period patient was treated with PROPOFOL (15 Mg Once Intravenous (nos)) (View Propofol Review and Propofol Label ), MIDAZOLAM HYDROCHLORIDE (View Midazolam Hydrochloride Review and Midazolam Hydrochloride Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

5092881-6 | Infection, Neuromuscular Block Prolonged, Scar, Surgical Procedure Repeated
Patient was taking Rocuronium (View Usage). Patient had the following side effects: infection (What is infection?), neuromuscular block prolonged, scar (What is scar?), surgical procedure repeated on Aug 14, 2006 from BELGIUM Additional patient health information: Female patient , 62 years of age, was diagnosed with neuromuscular blockade and. Rocuronium dosage: 40 Mg Once Intravenous (nos). During the same period patient was treated with AMIKACIN (Intravenous (nos)) (View Amikacin Review and Amikacin Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), BETABLOCKER (View Betablocker Review and Betablocker Label ), SARTAN (View Sartan Review and Sartan Label ), BETA 2 MIMETICS (View Beta-2 Mimetics Review and Beta-2 Mimetics Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5031773-5 | Anaphylactic Shock, Cardiac Arrest
Adverse event was reported on Jun 15, 2006 by a Female patient taking Rocuronium (View Usage) (Dosage: ) . Location: BELGIUM , 76 years of age, After Rocuronium was administered, patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?). During the same period patient was treated with CEFALOSPORINES (View Cefalosporines Review and Cefalosporines Label ), LATEX (View Latex Review and Latex Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ), ADHESIVE BANDAGES (View Adhesive Bandages Review and Adhesive Bandages Label ).

4778985-3 | Rash Maculo-papular
on Sep 19, 2005 Female patient from UNITED KINGDOM , child 12 years of age, was diagnosed with anaesthesia and was treated with Rocuronium (View Usage). Patient experienced the following unwanted or unexpected effects: rash maculo-papular. Rocuronium dosage: Intravenous (nos). During the same period patient was treated with ONDANSETRON (Intravenous (nos)) (View Ondansetron Review and Ondansetron Label ), MORPHINE (Intravenous (nos)) (View Morphine Review and Morphine Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.


4777330-7 | Hypotension, Syncope
on Mar 11, 2002 Male patient from AUSTRALIA , 73 years of age, was treated with Rocuronium (View Usage). Patient had the following side effects: hypotension, syncope. Rocuronium dosage: .

4766852-0 | Somnolence
Patient was taking Rocuronium (View Usage). After Rocuronium was administered, patient had the following side effects: somnolence on Sep 02, 2005 from AUSTRALIA Additional patient health information: Male patient , child 3 years of age, was diagnosed with pain (What is pain?) and. Rocuronium dosage: 9 Mg Once Intravenous (nos). During the same period patient was treated with NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), HALOTHANE (View Halothane Review and Halothane Label ), PARACETAMOL (375 Mg Rectal) (View Paracetamol Review and Paracetamol Label ), ATROPINE SULFATE (View Atropine Sulfate Review and Atropine Sulfate Label ), NEOSTIGMINE (View Neostigmine Review and Neostigmine Label ). Patient was hospitalized.

4757839-2 | Dyspnoea, Injection Site Irritation, Injection Site Pain, Miosis, Neuromuscular Blockade, Speech Disorder
Adverse event was reported on Aug 16, 2005 by a Male patient taking Rocuronium (View Usage) (Dosage: 100 Mg Once Epidural) . Location: TURKEY , 53 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, injection site irritation, injection site pain, miosis, neuromuscular blockade, speech disorder. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), ATROPINE (View Atropine Review and Atropine Label ).

4724688-0 | Post Procedural Complication, Respiratory Disorder
on Jul 20, 2005 Female patient from UNITED STATES , 72 years of age, weighting 249.1 lb, was diagnosed with paralysis (What is paralysis?), preoperative care, prophylaxis and was treated with Rocuronium (View Usage). Patient had the following side effects: post procedural complication, respiratory disorder. Rocuronium dosage: . During the same period patient was treated with CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

4690010-1 | Neuromuscular Block Prolonged
on Nov 11, 2004 Female patient from , 63 years of age, weighting 134.5 lb, was treated with Rocuronium (View Usage). After Rocuronium was administered, patient had the following side effects: neuromuscular block prolonged. Rocuronium dosage: 110 Mg Intravenous (nos). During the same period patient was treated with SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

4690009-5 | Neuromuscular Block Prolonged
Patient was taking Rocuronium (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged on Nov 11, 2004 from Additional patient health information: Female patient , 81 years of age, weighting 130.1 lb, was diagnosed with anaesthesia reversal and. Rocuronium dosage: 75 Mg Bid Intravenous (nos). During the same period patient was treated with NEOSTIGMINE (45 Mg Once Intravenous (nos)) (View Neostigmine Review and Neostigmine Label ), FORANE /USA/ (View Forane /usa/ Review and Forane /usa/ Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

4690008-3 | Neuromuscular Block Prolonged
Adverse event was reported on Nov 11, 2004 by a Male patient taking Rocuronium (View Usage) (Dosage: 120 Mg Once Intravenous (nos)) . Location: , 65 years of age, weighting 368.2 lb, Patient had the following side effects: neuromuscular block prolonged. During the same period patient was treated with NEOSTIGMINE (5 Mg) (View Neostigmine Review and Neostigmine Label ), FORANE /USA/ (View Forane /usa/ Review and Forane /usa/ Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ).

4620883-X | Anaesthetic Complication Neurological, Areflexia, Coma, Loss Of Consciousness, Pupillary Reflex Impaired
on Mar 17, 2005 Female patient from , 78 years of age, was diagnosed with induction and maintenance of anaesthesia and was treated with Rocuronium (View Usage). After Rocuronium was administered, patient had the following side effects: anaesthetic complication neurological, areflexia, coma, loss of consciousness, pupillary reflex impaired. Rocuronium dosage: 50 Mg Once/30 Mg Once,intravenous Bolus. During the same period patient was treated with PANCURONIUM (Intravenous Bolus) (View Pancuronium Review and Pancuronium Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NADOLOL (View Nadolol Review and Nadolol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ).